Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2009.62.pdf
Reference110 articles.
1. Dassonville, O., Bozec, A., Fischel, J. L. & Milano, G. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences. Crit. Rev. Oncol. Hematol. 62, 53–61 (2007).
2. Hirsch, F. R. & Bunn, P. A. Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations? J. Clin. Oncol. 23, 9044–9047 (2005).
3. Zhang, W., Gordon, M. & Lenz, H. J. Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies. Ann. Med. 38, 545–551 (2006).
4. Moosmann, N. & Heinemann, V. Cetuximab in the treatment of metastatic colorectal cancer. Expert Opin. Biol. Ther. 7, 243–256 (2007).
5. Rivera, F., Vega-Villegas, M. E., Lopez-Brea, M. F. & Marquez, R. Current situation of panitumumab, matuzumab, nimotuzumab and zalutuzumab. Acta Oncol. 47, 9–19 (2008).
Cited by 196 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic Reversal of Drug Resistance in Cancer;Targets;2024-09-13
2. A case of Ph+ acute lymphoblastic leukemia and EGFR mutant lung adenocarcinoma synchronous overlap: may one TKI drug solve two diseases?;BMC Medical Genomics;2024-07-08
3. Development of a Supermolecular Radionuclide-Drug Conjugate System for Integrated Radiotheranostics for Non-small Cell Lung Cancer;Journal of Medicinal Chemistry;2024-06-19
4. Brefeldin A and M-COPA block the export of RTKs from the endoplasmic reticulum via simultaneous inactivation of ARF1, ARF4, and ARF5;Journal of Biological Chemistry;2024-06
5. Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion;npj Precision Oncology;2024-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3